Deprescribing versus continuation of chronic proton pump inhibitor use in adults. - PubMed - NCBI https://t.co/q4hzWUF0Hk
RT @SaferMedsNL: That's a lot of prescriptions for #PPIs! Especially when you consider that data suggests that ~ 25-70% of people are presc…
RT @SaferMedsNL: That's a lot of prescriptions for #PPIs! Especially when you consider that data suggests that ~ 25-70% of people are presc…
That's a lot of prescriptions for #PPIs! Especially when you consider that data suggests that ~ 25-70% of people are prescribed a #PPI inappropriately. #deprescribe #reviewbeforerenewing https://t.co/hM11i3xqJX @OptimisingRxUse @DebbieVKelly @DeprescribeN
@drcesarpramirez Muy de acuerdo en que hay exceso de prescripción. A veces solo justificada x "es q tomo muchas pastillas" pero no está tan claro lo de los efectos secundarios vs beneficios a largo plazo en ERGE. https://t.co/nCEuSbN01d
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
Not easy to identify who will benefit from stopping but there certainly seems to be some overprescribing
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
This is relevant to all #GPPharmacists
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
RT @Deprescribing: “Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interac…
“Chronic #PPI use without reassessment contributes to #polypharmacy and puts people at risk of experiencing drug interactions and adverse events” Study explores the effects of #deprescribing long-term PPI therapy in adults https://t.co/QCfDtousYT
RT @syuichiao89: Deprescribing versus continuation of chronic proton pump inhibitor use in adults. - PubMed - NCBI https://t.co/q4hzWUF0Hk
Deprescribing versus continuation of chronic proton pump inhibitor use in adults. - PubMed - NCBI https://t.co/q4hzWUF0Hk
RT @syuichiao89: Deprescribing versus continuation of chronic proton pump inhibitor use in adults. - PubMed - NCBI https://t.co/q4hzWUF0Hk
RT @syuichiao89: Deprescribing versus continuation of chronic proton pump inhibitor use in adults. - PubMed - NCBI https://t.co/q4hzWUF0Hk
Deprescribing versus continuation of chronic proton pump inhibitor use in adults. - PubMed - NCBI https://t.co/q4hzWUF0Hk
Comparaison de l’arrêt ou de la réduction et du maintien à long terme de l’utilisation d’inhibiteurs de la pompe à… https://t.co/wmVWuL25rt
Stopping or reducing versus continuing long-term proton pump inhibitor use in adults https://t.co/OeEEtgrgOd from Cochrane reviews
Good to see you sweetheart! 🐰 My hobby is sех tourism. Now I'm in your town Find me by name ⏭ https://t.co/W8DVHoExCf https://t.co/HXyMiPYfJI
Good to see the evidence thanks @cochranecollab Deprescribing vs. continuation of chronic proton pump inhibitor... https://t.co/3D4oNnWZ7B
RT @AETSA_: #Cochrane_Publica #Rev_Sist #Desprescripción vs Continuación Inhibidores bomba protones https://t.co/FYYWdARh4A @Sefap_FAP @sem…
RT @AETSA_: #Cochrane_Publica #Rev_Sist #Desprescripción vs Continuación Inhibidores bomba protones https://t.co/FYYWdARh4A @Sefap_FAP @sem…
RT @AETSA_: #Cochrane_Publica #Rev_Sist #Desprescripción vs Continuación Inhibidores bomba protones https://t.co/FYYWdARh4A @Sefap_FAP @sem…
RT @Bibliosaude: Cochrane: Stopping or reducing versus continuing long-term proton pump inhibitor use in adults https://t.co/4PHcoOWrbP
RT @AETSA_: #Cochrane_Publica #Rev_Sist #Desprescripción vs Continuación Inhibidores bomba protones https://t.co/FYYWdARh4A @Sefap_FAP @sem…
RT @AETSA_: #Cochrane_Publica #Rev_Sist #Desprescripción vs Continuación Inhibidores bomba protones https://t.co/FYYWdARh4A @Sefap_FAP @sem…
RT @AETSA_: #Cochrane_Publica #Rev_Sist #Desprescripción vs Continuación Inhibidores bomba protones https://t.co/FYYWdARh4A @Sefap_FAP @sem…
#Cochrane_Publica #Rev_Sist #Desprescripción vs Continuación Inhibidores bomba protones https://t.co/FYYWdARh4A @Sefap_FAP @semfyc @sefh_
Cochrane: Stopping or reducing versus continuing long-term proton pump inhibitor use in adults https://t.co/4PHcoOWrbP
Deprescribing versus continuation of chronic proton pump inhibitor use in adults. - PubMed - NCBI https://t.co/2RaPFHp3CD
RT @CochraneLibrary: Limited #CochraneEvidence regarding long-term benefits and harms of #PPI reduction or discontinuation for #GERD: https…
Evidence is not straightforward for getting off #PPI long term for #GERD. Limited trials with high heterogeneity. Consider other risks! https://t.co/HtUcGcZvEG
RT @CochraneLibrary: Limited #CochraneEvidence regarding long-term benefits and harms of #PPI reduction or discontinuation for #GERD: https…
RT @CochraneLibrary: Limited #CochraneEvidence regarding long-term benefits and harms of #PPI reduction or discontinuation for #GERD: https…
RT @CochraneLibrary: Limited #CochraneEvidence regarding long-term benefits and harms of #PPI reduction or discontinuation for #GERD: https…
Limited #CochraneEvidence regarding long-term benefits and harms of #PPI reduction or discontinuation for #GERD: https://t.co/0R4YrzjLAi #GI
RT @rincondesisifo: (Cochrane) Efectos de la deprescripción de IBP en pac con ERGE https://t.co/NO8Huhe1v8
RT @rincondesisifo: (Cochrane) Efectos de la deprescripción de IBP en pac con ERGE https://t.co/NO8Huhe1v8
RT @FarmaOnco: "Stopping or reducing versus continuing long-term proton pump inhibitor use in adults" https://t.co/uB91s8OooE
"Stopping or reducing versus continuing long-term proton pump inhibitor use in adults" https://t.co/uB91s8OooE
RT @rincondesisifo: (Cochrane) Efectos de la deprescripción de IBP en pac con ERGE https://t.co/NO8Huhe1v8
(Cochrane) Efectos de la deprescripción de IBP en pac con ERGE https://t.co/NO8Huhe1v8
RT @Deprescribing: PPI deprescribing SR published @cochranecollab ; key part of #deprescribing g/l; target pts carefully + monitor! https:…
RT @Deprescribing: PPI deprescribing SR published @cochranecollab ; key part of #deprescribing g/l; target pts carefully + monitor! https:…
(Cochrane) Deprescribing versus continuation of chronic proton pump inhibitor use in adults https://t.co/7UrnrqFYHH #PtSafety via sanoysal…
(Cochrane) Deprescribing versus continuation of chronic proton pump inhibitor use in adults https://t.co/BMnyCrxblH #PtSafety
Stopping or reducing versus continuing long-term proton pump inhibitor use in adults https://t.co/vFoi6sAbbn
RT @Deprescribing: PPI deprescribing SR published @cochranecollab ; key part of #deprescribing g/l; target pts carefully + monitor! https:…
RT @Deprescribing: PPI deprescribing SR published @cochranecollab ; key part of #deprescribing g/l; target pts carefully + monitor! https:…
RT @Deprescribing: PPI deprescribing SR published @cochranecollab ; key part of #deprescribing g/l; target pts carefully + monitor! https:…
RT @Deprescribing: PPI deprescribing SR published @cochranecollab ; key part of #deprescribing g/l; target pts carefully + monitor! https:…
#deprescribing SR for #PPIs #cochrane Lots of hard work went into this. Enjoy. https://t.co/Krnuwhc52V
PPI deprescribing SR published @cochranecollab ; key part of #deprescribing g/l; target pts carefully + monitor! https://t.co/fncpm5hfhZ
Deprescribing versus continuation of chronic #PPI use in adults; new #Cochrane review https://t.co/bB3NqXR0SF
RT @diar_fattah: #Deprescribing vs Continuation of PPIs in adults via @CochraneUK https://t.co/8ReSbw5wjI https://t.co/82HmPSwmz3
#Deprescribing vs Continuation of PPIs in adults via @CochraneUK https://t.co/8ReSbw5wjI https://t.co/82HmPSwmz3